Clinical Ovarian Cancer was created in 2008.
Wisconsin Ovarian Cancer Alliance was created in 2001.
Genetically engineered Immunotherapy is an experimental drug for relapsed or resistant ovarian cancer and is still going through clinical trials.
Clinical Genitourinary Cancer was created in 2002.
Clinical Breast Cancer was created in 2000.
Clinical Colorectal Cancer was created in 2001.
Clinical Cancer Research was created in 1995.
Clinical Lung Cancer was created in 1999.
Some current clinical trial services in Ontario include women with breast cancer and lymphoma or ovarian cancer. There is also a study of those with silicon breast implants.
There is no evidence that HPV causes ovarian cancer.
Yes, ovarian cancer is sometimes referred to as ovarian carcinoma, which specifically denotes cancer that originates in the ovarian tissue. It can also be classified based on the type of cells involved, such as epithelial, germ cell, or stromal tumors, but "ovarian cancer" is the most commonly used term.
A pap smear will not detect ovarian cancer. Ovarian cancer won't affect whether a pap smear is normal or abnormal -- it could be either one.
Overall, ovarian cancer accounts for only 4% of all cancers in women